Nile Pharmaceuticals
NIPH
NIPH
The ordinary general meeting of Nile Co. for Pharmaceuticals & Chemical Industries endorsed FY14/15 budget estimate and investment plan.
Estimated budget showed that the company targets EGP 30 million profit including tax, compared with EGP 33 million in FY13/14, and actual EGP 28.893 million in FY12/13.
The company had posted 20.35% decline in net profit in the period July-December, 2013 to EGP 9 million compared to EGP 11.2 million a year earlier.
Estimated budget showed that the company targets EGP 30 million profit including tax, compared with EGP 33 million in FY13/14, and actual EGP 28.893 million in FY12/13.
The company had posted 20.35% decline in net profit in the period July-December, 2013 to EGP 9 million compared to EGP 11.2 million a year earlier.
Source:
Mubasher
